tiprankstipranks
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Cash flow

Compare
501 Followers

Supernus Pharmaceuticals Cash Flow

SUPN's free cash flow for Q4 2024 was $44.19M. For the 2024 fiscal year, SUPN's free cash flow was decreased by $60.69M and operating cash flow was $44.41M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 171.95M$ 111.08M$ 116.83M$ 127.13M$ 138.40M
Investing Cash Flow
$ -189.87M$ 268.73M$ -216.66M$ -81.91M$ -34.70M
Financing Cash Flow
$ 12.19M$ -397.88M$ -10.48M$ -130.42M$ 3.56M
End Cash Position
$ 69.33M$ 75.05M$ 93.12M$ 203.43M$ 288.64M
Free Cash Flow
$ 171.23M$ 110.53M$ 116.41M$ 125.08M$ 134.95M
Currency in USD

Supernus Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis